52389-677Level 3
Nauzene Chewables (Sodium citrate)
**Product type:** Human Otc Drug
**Active ingredient:** TRISODIUM CITRATE DIHYDRATE
**Strength:** 230 mg/1
**Dosage form:** Tablet, Chewable
**Route:** Oral
**Labeler:** Kobayashi Healthcare International, Inc.
**Marketing category:** OTC MONOGRAPH DRUG (M001)
**Pharmacologic class:** Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
GET
/api/v1/systems/ndc_fda/nodes/52389-677Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.